Konstantinos Dimas Selected Research

Konstantinos Dimas Research Topics

Disease

34	Neoplasms (Cancer) 01/2022 - 04/2003
7	Colonic Neoplasms (Colon Cancer) 01/2015 - 01/2006
5	Breast Neoplasms (Breast Cancer) 04/2022 - 12/2009
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019 - 09/2014
3	Adenocarcinoma 05/2022 - 04/2019
3	Prostatic Neoplasms (Prostate Cancer) 03/2020 - 04/2016
3	Colorectal Neoplasms (Colorectal Cancer) 01/2016 - 01/2009
2	Papillary Thyroid Cancer 12/2014 - 12/2011
2	Thyroid Neoplasms (Thyroid Cancer) 12/2014 - 12/2011
1	Ascites 11/2022
1	Carcinoma (Carcinomatosis) 11/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Parasitic Diseases (Parasitic Disease) 06/2021
1	Glioblastoma (Glioblastoma Multiforme) 06/2021
1	Glioma (Gliomas) 06/2021
1	Disease Progression 03/2020
1	Cicatrix (Scar) 01/2018
1	Wounds and Injuries (Trauma) 01/2018
1	Medulloblastoma 07/2017
1	Multiple Myeloma 10/2016
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2015
1	Heart Failure 06/2014
1	Lung Neoplasms (Lung Cancer) 06/2014
1	Carcinogenesis 12/2011
1	Follicular Adenocarcinoma 12/2011
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2011
1	Necrosis 10/2011

Drug/Important Bio-Agent (IBA)

11	Pharmaceutical PreparationsIBA 06/2021 - 01/2006
6	Liposomes (Liposome)IBA 06/2021 - 01/2006
4	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2022 - 01/2006
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2008
4	sclareolIBA 09/2011 - 01/2006
3	Biomarkers (Surrogate Marker)IBA 05/2022 - 01/2016
3	Adenosine Triphosphatases (ATPase)IBA 04/2016 - 01/2014
3	CurcuminIBA 01/2015 - 02/2007
3	lissamine rhodamine B (sulforhodamine B)IBA 03/2012 - 01/2006
2	Caveolin 1IBA 01/2022 - 01/2019
2	LigandsIBA 01/2021 - 12/2009
2	Mechanistic Target of Rapamycin Complex 2IBA 01/2021 - 12/2014
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2020 - 05/2008
2	Gemcitabine FDA Link 10/2018 - 03/2017
2	ProteomeIBA 07/2017 - 05/2008
2	Caspase 3 (Caspase-3)IBA 01/2017 - 04/2016
2	IstaroximeIBA 01/2017 - 04/2016
2	Androgen Receptors (Androgen Receptor)IBA 04/2016 - 12/2009
2	Ethanol (Ethyl Alcohol)IBA 01/2015 - 01/2009
2	OximesIBA 06/2014 - 01/2014
2	saccharinate(2,2'- 6',2'- terpyridine)palladium(II)IBA 10/2011 - 10/2011
2	Cisplatin (Platino)FDA LinkGeneric 10/2011 - 06/2009
2	PalladiumIBA 10/2011 - 10/2011
2	DiterpenesIBA 09/2011 - 04/2007
1	Chloroquine (Aralen)FDA LinkGeneric 11/2022
1	2-(dimethylamino)ethyl methacrylateIBA 04/2022
1	CarcinogensIBA 01/2022
1	TRAM 34IBA 06/2021
1	Phospholipids (Phosphatides)FDA LinkGeneric 06/2021
1	sigma Receptors (sigma Receptor)IBA 01/2021
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2021
1	AndrogensIBA 03/2020
1	abirateroneIBA 03/2020
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 03/2020
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 03/2020
1	ChloridesIBA 02/2020
1	Aquaporins (Water Channels)IBA 04/2019
1	HydrogelsIBA 10/2018
1	EnzymesIBA 10/2018
1	Biological ProductsIBA 01/2018
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2018
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2018
1	Analgesics (Analgesic Drugs)IBA 01/2018
1	Allopurinol (Remid)FDA LinkGeneric 01/2018
1	Nevirapine (Viramune)FDA Link 01/2018
1	SulfonamidesIBA 01/2018
1	Dapsone FDA Link 01/2018
1	celastrol methyl esterIBA 01/2018
1	abacavir (Ziagen)FDA Link 01/2018
1	annonacinIBA 01/2018
1	Focal Adhesion Protein-Tyrosine KinasesIBA 12/2017
1	CXCR4 Receptors (CXCR4 Receptor)IBA 12/2017
1	Histones (Histone)IBA 03/2017
1	Cytotoxins (Cytolysins)IBA 03/2017
1	NucleosidesIBA 03/2017
1	Nucleotide AptamersIBA 03/2017
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 01/2017
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 01/2017
1	Bortezomib (Velcade)FDA Link 10/2016
1	Endothelin-1 (Endothelin 1)IBA 10/2016
1	Phosphotransferases (Kinase)IBA 12/2014
1	Peptides (Polypeptides)IBA 09/2014
1	Digoxin (Digitek)FDA LinkGeneric 06/2014
1	Digitoxin FDA Link 06/2014
1	Sodium-Potassium-Exchanging ATPase (Sodium, Potassium ATPase)IBA 06/2014
1	FenretinideIBA 05/2014
1	3-hydroxyflavoneIBA 03/2012
1	Eukaryotic Initiation Factor-4EIBA 12/2011
1	TOR Serine-Threonine KinasesIBA 12/2011
1	Fluorescent Dyes (Fluorescent Probes)IBA 10/2011

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 01/2019 - 02/2007
3	Therapeutics 01/2022 - 03/2020
1	Transplantation 06/2021